UNICA IRIS Institutional Research Information System

DEFAZIO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 175.534
NA - Nord America 17.001
AS - Asia 7.905
SA - Sud America 1.988
Continente sconosciuto - Info sul continente non disponibili 1.113
AF - Africa 224
OC - Oceania 26
Totale 203.791
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 172.226
US - Stati Uniti d'America 16.583
SG - Singapore 3.229
CN - Cina 2.199
BR - Brasile 1.553
VN - Vietnam 968
SE - Svezia 669
FR - Francia 429
UA - Ucraina 410
DE - Germania 407
FI - Finlandia 364
GB - Regno Unito 358
HK - Hong Kong 316
CA - Canada 238
IN - India 196
BD - Bangladesh 186
NL - Olanda 171
AR - Argentina 169
TR - Turchia 123
KR - Corea 97
MX - Messico 93
JP - Giappone 84
EC - Ecuador 78
RU - Federazione Russa 71
ID - Indonesia 70
IQ - Iraq 70
AT - Austria 67
ZA - Sudafrica 63
ES - Italia 60
CO - Colombia 56
PL - Polonia 46
PK - Pakistan 45
PH - Filippine 40
MA - Marocco 37
SA - Arabia Saudita 36
CH - Svizzera 35
VE - Venezuela 32
CL - Cile 30
IE - Irlanda 30
UZ - Uzbekistan 28
EG - Egitto 27
IR - Iran 27
PY - Paraguay 27
RO - Romania 27
JM - Giamaica 23
AE - Emirati Arabi Uniti 22
PE - Perù 22
BE - Belgio 21
KE - Kenya 21
MY - Malesia 21
CZ - Repubblica Ceca 20
IL - Israele 20
AL - Albania 17
NP - Nepal 17
TN - Tunisia 17
TW - Taiwan 16
AU - Australia 15
GR - Grecia 14
JO - Giordania 13
DO - Repubblica Dominicana 12
DZ - Algeria 12
PT - Portogallo 12
AZ - Azerbaigian 11
BG - Bulgaria 11
NZ - Nuova Zelanda 11
CR - Costa Rica 10
KZ - Kazakistan 10
RS - Serbia 10
UY - Uruguay 10
ET - Etiopia 9
LT - Lituania 9
BO - Bolivia 8
HN - Honduras 8
PA - Panama 8
PS - Palestinian Territory 8
HU - Ungheria 7
LB - Libano 7
NG - Nigeria 7
OM - Oman 7
TH - Thailandia 7
GH - Ghana 6
KG - Kirghizistan 6
MG - Madagascar 6
DK - Danimarca 5
GT - Guatemala 5
HR - Croazia 5
LV - Lettonia 5
QA - Qatar 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
KH - Cambogia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
LU - Lussemburgo 3
MU - Mauritius 3
SN - Senegal 3
Totale 202.631
Salva come PNG Salva come JPEG
Città #
Cagliari 161.691
Uta 5.701
Fairfield 2.306
Ashburn 1.587
Singapore 1.281
Woodbridge 982
Seattle 899
Boardman 842
Houston 831
San Jose 778
Dallas 777
Wilmington 755
Cambridge 740
Nyköping 496
Beijing 449
Ann Arbor 444
Milan 427
Rome 409
Helsinki 338
Chandler 322
Ho Chi Minh City 322
Los Angeles 321
Council Bluffs 320
The Dalles 312
Hong Kong 273
New York 246
Lauterbourg 238
Shanghai 229
Boston 225
Hanoi 221
Jacksonville 215
Santa Clara 178
Nanjing 165
Buffalo 160
São Paulo 150
Guangzhou 147
Munich 125
Toronto 125
San Diego 124
Dearborn 111
Naples 108
Turin 87
London 84
Bologna 82
Redwood City 79
Catania 74
Florence 67
Millbury 63
Bari 62
Chicago 59
Norwalk 59
Shenyang 59
Tianjin 57
Dong Ket 56
Trabzon 56
Seoul 54
Augusta 53
Changsha 53
Hefei 52
Orem 50
Nuremberg 49
Frankfurt am Main 48
Tokyo 47
Rio de Janeiro 45
Palermo 44
Verona 44
Haiphong 40
Jiaxing 40
Da Nang 39
Hebei 39
Atlanta 38
Redondo Beach 38
Nanchang 37
Genoa 33
Phoenix 33
Vienna 33
Curitiba 32
Padova 32
San Mateo 31
Brasília 30
Chennai 30
Guayaquil 30
Montreal 30
Wuhan 30
Brooklyn 29
Denver 29
Belo Horizonte 28
Brescia 27
Mexico City 27
Mountain View 26
Sassari 25
Shenzhen 25
Tashkent 25
Baghdad 23
Biên Hòa 23
Düsseldorf 23
Hải Dương 23
Parma 23
Johannesburg 22
Mumbai 22
Totale 188.868
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.356
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.475
Neurosifilide e stroke ischemico: case report. 4.016
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.347
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.038
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.755
Epilessia mioclonica progressiva o epilessia parziale continua? 2.534
Gender differences in olfactory function in patients with Parkinson's disease. 2.472
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease 2.379
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.370
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 2.333
Sleep cardiac dysautonomia and EEG oscillations in Amyotrophic Lateral Sclerosis 2.278
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.272
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.205
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.167
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.131
Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease 2.125
CORRELATION AMONG OLFACTORY DYSFUNCTION, APATHY AND FATIGUE IN PATIENTS WITH PARKINSON’S DISEASE 2.087
Upper limb movements in dementia with Lewy body: a quantitative analysis 1.975
Sensory trick in upper limb dystonia 1.971
Pulvinar sign in a case of anti-CV2 encephalitis 1.911
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.891
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.763
NCSE: un caso di steroid-responsive encephalopathy associated with autoimmune thyroiditis 1.755
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.680
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.653
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.603
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 1.563
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.562
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.554
Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension) 1.533
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.428
The Relationships Between Ataxia and Cognition in Spinocerebellar Ataxia Type 2 1.412
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 1.299
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 1.279
Cerebellar Syndrome Associated with Thyroid Disorders 1.232
Does the network model fits neurophysiological abnormalities in blepharospasm? 1.224
Serum anti-thyroid antibodies in Hashimoto’s encephalopathy: A never-ending story 1.224
Idiopathic Non-Task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia 1.192
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 1.175
Cannabinoids and dystonia: an issue yet to be defined 1.166
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence. 1.152
Functional neurological disorder after COVID-19 vaccination 1.098
Movement disorders phenomenology in focal motor seizures 1.088
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.054
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 1.052
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 1.034
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? 1.025
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 968
The role of sensory information in the pathophysiology of focal dystonias 966
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 953
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 952
Status epilepticus in Hashimoto's encephalopathy 952
Effects of White Matter Hyperintensities on Brain Connectivity and Hippocampal Volume in Healthy Subjects According to Their Localization 951
Persistent myoclonic jerks: a case of epilepsia partialis continua or myoclonic progressive epilepsy? 904
Qualitative smell/taste disorders as sequelae of acute COVID-19 903
Diagnostic criteria for blepharospasm: A multicenter international study 886
Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy 885
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm 882
Effetti della stimolazione del nervo vago sulle componenti aperiodiche dell’EEG in soggetti affetti da epilessia resistente ai farmaci 874
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 871
Disease progression in blepharospasm: a 5-year longitudinal study 864
Risk factors of Parkinson disease. Simultaneous assessment, interactions, and etiologic subtypes 859
Rasagiline withdrawal Syndrome in Parkinson’s Disease 851
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 848
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 802
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 800
Validation of a guideline to reduce variability in diagnosing cervical dystonia 768
Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies 768
23. Effects of vagal nerve stimulation on EEG aperiodic parameters in subjects affected by drug-resistant epilepsy 764
Pain in Parkinson's disease: facts and uncertainties 751
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 748
Neuroimaging in idiopathic adult-onset focal dystonia 733
Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature 711
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability 710
Whole-exome sequencing for variant discovery in blepharospasm 688
Pain in focal dystonias - A focused review to address an important component of the disease 685
Global Fractional Anisotropy: Effect on Resting-state Neural Activity and Brain Networking in Healthy Participants 684
Early juvenile reading epilepsy and later frontotemporal dementia (FTD): expanding the clinical phenotype of C9ORF72 mutation? 681
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 680
Estimated EEG functional connectivity and aperiodic component induced by vagal nerve stimulation in patients with drug-resistant epilepsy 679
The mid-term effects of carotid endarterectomy on cognition and regional neural activity analyzed with the amplitude of low frequency fluctuations technique 674
Functional gait disorders: Demographic and clinical correlations 655
Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy 652
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 650
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 649
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations. 638
Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications 631
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 626
Functional neurological disorders as seen by a cohort of general practitioners in northern italy: Evidence from an online survey 624
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 598
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 588
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time 585
Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia? 584
Effect of botulinum toxin on non-motor symptoms in cervical dystonia 581
Involuntary Thumb Flexion on Neurological Examination: An Unusual Form of Upper Limb Dystonia in the Faroe Islands 575
The Italian Dystonia Registry: rationale, design and preliminary findings 573
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease 566
Cocaine-induced Pisa syndrome 566
Blepharospasm 40 years later 554
Totale 150.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 323.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 323.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.092 0 1.000 644 773 987 875 983 744 940 1.152 1.389 1.605
2022/202319.596 1.827 2.335 2.144 1.487 1.453 1.613 1.089 2.658 1.171 1.325 1.535 959
2023/202425.018 1.230 906 1.098 2.041 2.370 3.627 4.003 1.727 1.174 1.800 2.619 2.423
2024/202563.650 16.422 11.979 13.964 7.540 3.018 3.629 4.114 268 840 912 403 561
2025/202613.750 1.149 434 1.871 1.923 915 925 2.313 627 1.042 1.320 640 591
2026/20271.136 489 647 0 0 0 0 0 0 0 0 0 0
Totale 203.791